COVID-19 impact survey for families.
A survey looking at the Covid-19 impact on wellbeing in families of children with rare neurodevelopmental and genetic disorders study
A survey looking at the Covid-19 impact on wellbeing in families of children with rare neurodevelopmental and genetic disorders study
Pompe Support Team’s Medical Overview leaflet is now being used in Australia.
Audentes is now enrolling patients with late-onset Pompe disease in the Phase 1/2 clinical trial.
AGSD-UK are offering a free online mindfulness course to those working with or affected by GSD.
This webinar will explore educating physicians in rare diseases. It is open to all.
Metabolic Disorders Awareness Week runs from 06.07.20 – 12.07.20. see how you can be part of it.